Experiences with tumour necrosis factor- inhibitors in patients with juvenile idiopathic arthritis: Hungarian data from the National Institute of Rheumatology and Physiotherapy Registry-Reference-Cited by-同舟云学术

Experiences with tumour necrosis factor- inhibitors in patients with juvenile idiopathic arthritis: Hungarian data from the National Institute of Rheumatology and Physiotherapy Registry

Published:2011-03-03 Issue:7 Volume:50 Page:1337-1340
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Sevcic K.,Orban I.,Brodszky V.,Bazso A.,Balogh Z.,Poor G.,Kiss E.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/50/7/1337/5065269/ker103.pdf

Reference14 articles.

1. Preliminary definition of improvement in juvenile arthritis

2. Penicillamine and Hydroxychloroquine in the Treatment of Severe Juvenile Rheumatoid Arthritis

3. Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis in children and adolescents with rheumatic diseases using biologic agents: an integrative review;Revista Paulista de Pediatria;2024

2. Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study;Pediatric Rheumatology;2022-11-14

3. Determinants of Tumor Necrosis Factor Inhibitor Use in Juvenile Spondyloarthropathy and Impact on Clinical Disease Outcomes;ACR Open Rheumatology;2021-10-14

4. TNF-Alpha Inhibitors and Rhinosinusitis—A Systematic Review and Meta-Analysis;American Journal of Rhinology & Allergy;2020-01-23

5. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA);Annals of the Rheumatic Diseases;2015-04-29